Form 4 for ANIP ANI PHARMACEUTICALS INC
Accepted 2026-06-10 21:06:55 ET · period of report 2026-05-21 · accession 0001272247-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-10 21:06 | 2026-05-21 | ANIP | HAUGHEY THOMAS | Dir | A - Grant | $0.00 | +4,357 | 40.9K | +12% | $0 |
| T | 2026-06-10 21:06 | 2026-06-08 | ANIP | HAUGHEY THOMAS | Dir | S - Sale | $80.88 | -2,000 | 38.9K | -5% | -$161.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-21 | A | A | 4,357 | $0.00 | 40,878 | D | — | — | (F1) Represents a restricted stock award that will vest in full on May 21, 2027. |
| 2 | Common | Common Stock | 2026-06-08 | S | D | 2,000 | $80.88 | 38,878 | D | — | — | (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2026. |